The biopharmaceuticals contract manufacturing market is expected to reach US$ 25,497.26 million by 2027



The biopharmaceutical market has grown into a significant and promising segment of the overall pharmaceutical industry over the years. The market is poised for significant growth in the coming years, thanks to a number of blockbusters therapies (Humira, Rituxan, Lantus, Avastin, Herceptin, and Remicade) and a robust pipeline of product/therapy candidates.

The biologics contract manufacturing market is expected to grow significantly over the forecast period of 2020-2030, owing to a growing demand for biologics professionals and an increase in the signing of agreements between pharmaceutical companies and biologics contract manufacturing organizations. Biologics contract manufacturing organizations provide all services under one roof, from research and development to dosage preparation and packaging. As a result, this factor is a key growth indicator for the biologics contract manufacturing market.

Manufacturers in the biopharmaceutical contract manufacturing market are focusing on revamping various features in response to technological advancements, as well as lowering production costs. These factors contribute to the efficient production of drugs and their affordable availability to the general public. As a result of these factors, the biologics contract manufacturing market may see exceptional growth opportunities.

The biopharmaceuticals contract manufacturing market was worth US$ 13,727.13 million in 2019 and is expected to grow at an 8.2 percent CAGR from 2020 to 2027, reaching US$ 25,497.26 million by 2027.

Biopharmaceutical contract manufacturing industry trends were discussed by biomanufacturing directors from pharmaceutical and biotechnology companies. The majority of respondents anticipate continued industry growth. Some of the reasons for their assessment include a) an increase in the biopharmaceutical pipeline, b) an increase in cell and gene therapies, and c) an increase in small biotechnology companies with no in-house research and development.

The global biopharmaceuticals contract manufacturing market is divided into two components: products and services. By product, the biopharmaceuticals contract manufacturing market is divided into biologics and biosimilars. The biologics segment held the largest market share in 2019, while the biosimilar segment is expected to grow at the fastest rate during the forecast period. The market is divided into three sections based on services: development process, final dosage operations, and final packaging. The development process had the largest market share in 2019, while the analytical and quality control segment is expected to have the highest CAGR during the forecast period.

By service, the biopharmaceuticals contract manufacturing market is divided into the development process, final dosage operations, analytical and quality control, and final packaging. Because of cutting-edge technologies, the development process accounted for the largest market share in the global biopharmaceuticals contract manufacturing market in 2019. As a result, the risk for small drug manufacturers has increased.

Product launches and expansion strategies are commonly used by businesses to expand their global footprint and meet rising demand. This strategy is most commonly used by market players to expand their product portfolio. The biopharmaceuticals contract manufacturing market players adopted a product innovation strategy to cater to changing customer demand around the world, which also allows the players to maintain their brand name globally.

Contract Manufacturing of Biopharmaceuticals in the Global Market by-product:-

·        Biologics

·        Biosimilars

By Service:-                                                                                                   

·        Development Process

·        Final Dosage Operation

·        Analytical and Quality Control

·        Final Packaging

By Geography:-

1.     North America

  •         US
  •         Canada
  •           Mexico

2.     Europe

  •     France
  •      Germany
  •         Italy
  •         UK
  •         Spain
  •         Rest of Europe

 

3.     Asia Pacific

  •         China
  •         India
  •         South Korea
  •         Japan
  •         Australia
  •         Rest of Asia Pacific

 

4.     Middle East & Africa

  •         South Africa
  •         Saudi Arabia
  •         UAE
  •         Rest of Middle East and Africa

 

5.     South America

·        Brazil

·        Argentina

·        Rest of South America

 

 

 

 


Comments

Post a Comment

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Image
  By 2027, the global market for Quats (Quaternary Ammonium Compounds) is expected to reach USD 1.63 billion. The market is being driven by the rise in the occurrence of hospital-acquired infections (HAIs) and the implementation of stringent regulations and favorable government initiatives on disinfection and sterilization. Developing economies are expected to give significant opportunities for growth. Fabric softeners, disinfectants, surfactants, antistatic agents, and wood preservation are just a few of the uses for quaternary ammonium compounds. The product's numerous applications are projected to raise demand shortly. Quaternary ammonium compounds are commonly employed as conditioning agents in personal care products, such as skin, textile, and hair softeners. The surfactant industry considers QACs to be the ultimate workhorse. They're on the USEPA's "High Production Volume Chemicals" list. Self-assembly, surface-active properties, detergency, and antibact...
Read more

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Image
  Buthylaldehyde (also known as butanal) is a 4-carbon aldehyde that is used as a building block in organic syntheses to make various products such as n-butanol, 2-ethyl hexanol, 2-ethyl hexanoic acid, trimethylolpropane, and polyvinyl butyral. Pharmaceuticals, agrochemicals, antioxidants, textile auxiliaries, perfumes, flavors, and many forms of additives are all made with it as an intermediate (fillers, wetting agents, defoaming agents, improvers). Alcohols (mono- and multi-hydroxide), acids, amines, and esters are all made from N-butyraldehyde as a raw material. Rubber accelerators, synthetic resins, plasticizers, solvents, and high molecular weight polymers are the biggest uses of butyraldehyde. All of these buthylaldehyde applications are detailed in this study. Butyraldehyde is widely used as a starting material for the downstream organic synthesis of n-butanol, trimethylolpropane, 2-ethyl hexanoic acid, and polyvinyl butyral. Pharmaceutical intermediates, synthetic resins,...
Read more

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area

Image
Glass mat thermoplastic is a thermoplastic that can be easily moulded and is used to make a variety of components, primarily in the automotive industry. Because of the longer residual length of the glass strands, glass mat thermoplastic has better mechanical properties than injection moulded reinforced thermoplastic. It is primarily used as a replacement for steel and aluminium. They are available in panel form as well as 3D structural component form. Furthermore, they are a lightweight material with a low relative density, excellent hardness and rigidity at low temperatures, and are chemical and moisture resistant . These are durable materials with ease of recyclability. Furthermore, the demand for the glass mat thermoplastic material from the automobile and aeration industries leads to market growth. When compared to other end-use industries, the automotive application segment is expected to remain the largest. Furthermore, a surge in government initiatives for increased fuel eco...
Read more